Trials / Completed
CompletedNCT00913341
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg
Bioavailability of Alprazolam Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Alprazolam tablets, 1 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alprazolam Tablets, 1 mg (Geneva Pharmaceuticals) | |
| DRUG | Alprazolam Tablets, 1 mg (The Upjohn Company) |
Timeline
- Start date
- 1991-11-01
- Primary completion
- 1991-11-01
- Completion
- 1991-11-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913341. Inclusion in this directory is not an endorsement.